CompareMarketResearchRequest a sample
Home / Testing Equipment / Medical Device Testing

Testing Equipment · Market report

Medical Device Testing Market Size, Share and Forecast 2026-2036

The global medical device testing market is worth USD 11.3 bn in 2026 and is forecast to reach USD 24.5 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Biocompatibility and toxicology is the largest by test type segment.

USD 11.3 bnMarket size 2026
USD 24.5 bnForecast 2036
8.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global medical device testing market is worth USD 11.3 bn in 2026 and is forecast to reach USD 24.5 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Biocompatibility and toxicology is the largest by test type segment.

ScopeBiocompatibility, sterility, electrical safety, performance and packaging testing services for medical devices required for regulatory approval, supplied by independent laboratories and test houses.
IndustryTesting Equipment
Value 2025USD 10.5 bn
Value 2026USD 11.3 bn
Value 2036USD 24.5 bn
CAGR 2026-20368.0%
Volume 2026371 thousand test programmes
Volume 2036656 thousand test programmes
Average price 2026USD 30,600 per test programme
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Medical Device Testing market size and forecast, 2026-2036

Exhibit 1The global medical device testing market is forecast to grow from USD 11.3 bn in 2026 to USD 24.5 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 8.0%
Medical Device Testing market value, 2025 to 2036Market value by year. 2025: USD 10.5 bn; 2026: USD 11.3 bn; 2027: USD 12.2 bn; 2028: USD 13.2 bn; 2029: USD 14.3 bn; 2030: USD 15.4 bn; 2031: USD 16.7 bn; 2032: USD 18.0 bn; 2033: USD 19.4 bn; 2034: USD 21.0 bn; 2035: USD 22.7 bn; 2036: USD 24.5 bn. Compound annual growth rate 2026 to 2036: 8.0%.202511.3 bn202616.7 bn203124.5 bn20368.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 11.3 bn
2027USD 12.2 bn
2028USD 13.2 bn
2029USD 14.3 bn
2030USD 15.4 bn
2031USD 16.7 bn
2032USD 18.0 bn
2033USD 19.4 bn
2034USD 21.0 bn
2035USD 22.7 bn
2036USD 24.5 bn

Medical Device Testing market segmentation

By test type

Exhibit 2Biocompatibility and toxicology is the largest segment by test type, with 26.0% of 2026 revenueEstimated share of 2026 global revenue, by test type
Medical Device Testing market share by test type, 2026Share of 2026 revenue by test type. Biocompatibility and toxicology: 26.0%; Sterilization and microbiology: 22.0%; Performance and mechanical: 20.0%; Electrical safety and EMC: 18.0%; Packaging and shelf life: 14.0%.Biocompatibility and toxicology26.0%Sterilization and microbiology22.0%Performance and mechanical20.0%Electrical safety and EMC18.0%Packaging and shelf life14.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Biocompatibility and toxicology26.0%27.0%USD 2.9 bn8.4%
Sterilization and microbiology22.0%20.8%USD 2.5 bn7.4%
Electrical safety and EMC18.0%17.0%USD 2.0 bn7.4%
Performance and mechanical20.0%20.7%USD 2.3 bn8.4%
Packaging and shelf life14.0%14.5%USD 1.6 bn8.4%

By device class

Exhibit 3Class II adds the most revenue by device class, growing from USD 5.4 bn in 2026 to USD 11.6 bn by 2036Estimated revenue in USD by device class, 2026 and 2036 forecast
Medical Device Testing market by device class, 2026 and 2036Revenue by device class in 2026 and 2036. Class II: USD 5.4 bn in 2026, USD 11.6 bn in 2036, change +113%; Class III and implants: USD 3.4 bn in 2026, USD 7.9 bn in 2036, change +134%; Class I: USD 1.4 bn in 2026, USD 2.5 bn in 2036, change +85%; In vitro diagnostics: USD 1.1 bn in 2026, USD 2.4 bn in 2036, change +113%.20262036 forecastChangeClass II+113%5.4 bn11.6 bnClass III and implants+134%3.4 bn7.9 bnClass I+85%1.4 bn2.5 bnIn vitro diagnostics+113%1.1 bn2.4 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Class II48.0%47.4%USD 5.4 bn7.9%
Class III and implants30.0%32.5%USD 3.4 bn8.9%
Class I12.0%10.3%USD 1.4 bn6.4%
In vitro diagnostics10.0%9.9%USD 1.1 bn7.9%

By provider

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Independent labs62.0%60.0%USD 7.0 bn7.7%
Manufacturer in-house labs24.0%24.0%USD 2.7 bn8.0%
Notified bodies and regulators14.0%16.0%USD 1.6 bn9.4%

By device technology

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Active devices34.0%36.0%USD 3.9 bn8.6%
Implants20.0%20.0%USD 2.3 bn8.0%
Single-use consumables26.0%26.0%USD 2.9 bn8.0%
Diagnostic and software20.0%18.0%USD 2.3 bn6.9%

By regulatory region

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
FDA 510k and PMA40.0%38.0%USD 4.5 bn7.5%
EU MDR28.0%26.0%USD 3.2 bn7.2%
Asia and other32.0%36.0%USD 3.6 bn9.3%

Top 25 countries for medical device testing by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 84.0% of 2026 revenue and the 25 countries below together hold 95.9%.

Exhibit 4United States is the largest country market at USD 4.1 bn in 2026, and the three largest countries hold 54.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Medical Device Testing market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 4.1 bn, 36.0%; Germany: USD 1.0 bn, 9.0%; China: USD 1.0 bn, 9.0%; United Kingdom: USD 680 mn, 6.0%; Japan: USD 567 mn, 5.0%; France: USD 567 mn, 5.0%; Ireland: USD 454 mn, 4.0%; Switzerland: USD 454 mn, 4.0%; Netherlands: USD 340 mn, 3.0%; India: USD 340 mn, 3.0%.United States4.1 bn 36.0%Germany1.0 bn 9.0%China1.0 bn 9.0%United Kingdom680 mn 6.0%Japan567 mn 5.0%France567 mn 5.0%Ireland454 mn 4.0%Switzerland454 mn 4.0%Netherlands340 mn 3.0%India340 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 4.1 bn36.0%USD 8.3 bn7.4%
2GermanyUSD 1.0 bn9.0%USD 2.2 bn7.9%
3ChinaUSD 1.0 bn9.0%USD 2.7 bn10.4%
4United KingdomUSD 680 mn6.0%USD 1.4 bn7.5%
5JapanUSD 567 mn5.0%USD 1.1 bn6.4%
6FranceUSD 567 mn5.0%USD 1.2 bn7.3%
7IrelandUSD 454 mn4.0%USD 979 mn8.0%
8SwitzerlandUSD 454 mn4.0%USD 979 mn8.0%
9NetherlandsUSD 340 mn3.0%USD 734 mn8.0%
10IndiaUSD 340 mn3.0%USD 1.1 bn12.0%
11CanadaUSD 189 mn1.7%USD 419 mn8.3%
12SpainUSD 167 mn1.5%USD 345 mn7.5%
13SwedenUSD 146 mn1.3%USD 304 mn7.6%
14AustriaUSD 129 mn1.1%USD 267 mn7.5%
15BelgiumUSD 113 mn1.0%USD 235 mn7.6%
16IsraelUSD 100 mn0.9%USD 220 mn8.2%
17TaiwanUSD 87 mn0.8%USD 193 mn8.3%
18SingaporeUSD 77 mn0.7%USD 171 mn8.3%
19MexicoUSD 68 mn0.6%USD 169 mn9.5%
20AustraliaUSD 60 mn0.5%USD 132 mn8.2%
21ItalyUSD 52 mn0.5%USD 110 mn7.8%
22PolandUSD 46 mn0.4%USD 115 mn9.5%
23DenmarkUSD 41 mn0.4%USD 86 mn7.7%
24FinlandUSD 36 mn0.3%USD 73 mn7.3%
25MalaysiaUSD 32 mn0.3%USD 78 mn9.4%
Rest of worldUSD 469 mn4.1%USD 950 mn7.3%
Exhibit 5United States and China account for 46% of the USD 13.1 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Medical Device Testing market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 11.3 bn. United States: +USD 4.3 bn; China: +USD 1.7 bn; Germany: +USD 1.2 bn; United Kingdom: +USD 715 mn; India: +USD 713 mn; 20 other countries: +USD 4.1 bn; Rest of world: +USD 480 mn. Market value 2036: USD 24.5 bn.Market value 202611.3 bnUnited States+4.3 bnChina+1.7 bnGermany+1.2 bnUnited Kingdom+715 mnIndia+713 mn20 other countries+4.1 bnRest of world+480 mnMarket value 203624.5 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Eurofins Scientific
  • SGS
  • Intertek
  • TUV SUD
  • UL Solutions
  • Element Materials Technology
  • Bureau Veritas
  • TUV Rheinland

Group 2: Regional and specialist players

  • Nelson Labs
  • NAMSA
  • WuXi AppTec
  • Charles River Laboratories
  • DEKRA
  • Applus+
  • Smithers
  • Tentamus
  • STERIS AST
  • American Preclinical Services

Group 3: Emerging and niche players

  • Pacific BioLabs
  • Toxikon
  • Medistri
  • Wickham Laboratories
  • BioScreen Testing Services
  • Lucideon
  • Hohenstein

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the medical device testing market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.0% is calculated from the resulting values.

The market is divided by test type, by device class, by provider, by device technology, by regulatory region. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the medical device testing market?

The global medical device testing market is estimated at USD 10.5 bn in 2025 and USD 11.3 bn in 2026.

How fast will the medical device testing market grow?

It is forecast to reach USD 24.5 bn by 2036, a compound annual growth rate of 8.0% from 2026, an increase of USD 13.1 bn.

Which country is the largest market for medical device testing?

United States is the largest market by revenue at USD 4.1 bn in 2026, 36.0% of the global total. The three largest countries together hold 54.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 12.0% a year from 2026 to 2036.

Which medical device testing segment is largest?

In the by test type split, Biocompatibility and toxicology is the largest segment with 26.0% of 2026 revenue.

Who are the leading medical device testing companies?

Global leaders include Eurofins Scientific, SGS, Intertek, TUV SUD.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Testing Equipment

← Measurement Instrument Micrometer →

All Testing Equipment markets →

Request a sample